N-3 Fatty acid intake from marine food products among Quebecers: Comparison to worldwide recommendations

Public Health Nutrition

Volumn 13, Issue 1, 2010, Pages 63-70

  Lucas, Michel ^a,b   Asselin, Geneviève ^a   Plourde, Mélanie ^c   Cunnane, Stephen C ^c   Dewailly, Éric ^a,b   Dodin, Sylvie ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Fish; Marine food products; N 3 Fatty acids; Seafood

Indexed keywords

DOCOSAHEXAENOIC ACID; EDIBLE OIL; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; MIDDLE AGED; NUTRITION; NUTRITIONAL REQUIREMENT; SEA FOOD;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; NUTRITION POLICY; NUTRITION SURVEYS; NUTRITIONAL REQUIREMENTS; QUEBEC; SEAFOOD; YOUNG ADULT;

EID: 75149180083     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980009005679     Document Type: Article

References (58)

1. Simopoulos AP (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60, 502-507.
2. Harris WS (2006) The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 8, 453-459.
3. Kris-Etherton PM, Harris WS & Appel LJ (2002) AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
4. Calder PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 6 Suppl., 1505S-1519S.
5. Plourde M & Cunnane S (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619-634.
6. Lucas M, Asselin G, Mérette C, Poulin MJ & Dodin S (2008) Validation of an FFQ for evaluation of EPA and DHA intake. Public Health Nutr (Epublication ahead of print version).
7. Anderson CA & Appel LJ (2006) Dietary modification and CVD prevention: a matter of fat. JAMA 295, 693-695.
8. Mosca L, Appel LJ, Benjamin EJ et al. (2004) Evidencebased guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 24, e29-e50.
9. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS & Lau J (2006) n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primaryand secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5-17.
10. Freeman MP, Hibbeln JR, Wisner KL et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
11. Gebauer SK, Psota TL, Harris WS & Kris-Etherton PM (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, 6 Suppl., 1526s-1535s.
12. Makrides M (2008) Outcomes for mothers and their babies: do n-3 long-chain polyunsaturated fatty acids and seafoods make a difference? J Am Diet Assoc 108, 1622-1626.
13. Crawford MA (2000) Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants. Am J Clin Nutr 71, 1 Suppl., 275s-284s.
14. Innis SM (2003) Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 143, 4 Suppl., 1s-8s.
15. Cunnane SC, Francescutti V, Brenna JT & Crawford MA (2000) Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formulafed infants not consuming dietary docosahexaenoate. Lipids 35, 105-111.
16. Carlson SE (2009) Docosahexaenoic acid supplementation in pregnancy and lactation. Am J Clin Nutr 89, 678s-684s.
17. Francois CA, Connor SL, Bolewicz LC & Connor WE (2003) Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 77, 226-233.
18. Koletzko B, Cetin I & Thomas Brenna J (2007) Dietary fat intakes for pregnant and lactating women. Br J Nutr 98, 873-877.
19. Simopoulos AP, Leaf A & Salem N Jr (2000) Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 63, 119-121.
20. Santé-Québec (1995) Les Québécoises et Québécois mangent-ils mieux? Rapport de l'enquête québécoise sur la nutrition, 1990 (Report of the Nutrition Survey among Quebecers, 1990). Montréal: Ministère de la santé et des services sociaux, Gouvernement du Québec.
21. Dewailly E, Blanchet C, Gingras S, Lemieux S & Holub BJ (2003) Fish consumption and blood lipids in three ethnic groups of Quebec (Canada). Lipids 38, 359-365.
22. Kris-Etherton P, Taylor DS & Yu-Poth S (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71, Suppl. 1, 179s-188s.
23. Singh SR & Levine MA (2006) Natural health product use in Canada: analysis of the National Population Health Survey. Can J Clin Pharmacol 13, e240-e250.
24. Cardiovascular Review Group, Committee on Medical Aspects of Food Policy (1994) Nutritional Aspects of Cardiovascular Disease. Report on Health and Social Subjects. London, UK: Department of Health.
25. Food and Nutrition Board (FNB) of the Institute of Medicine of the National Academies (2002) Dietary fats: total fat and fatty acids. In Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fats, Fatty Acids, Cholesterol, Protein and Amino Acids (Macronutrients), pp. 422-541. Washington, DC: The National Academies Press; available at http://newton.nap.edu/books/ 0309085373/html/422.html
26. Eurodiet (2000) Nutrition & diet for healthy lifestyles in Europe. http://eurodiet.med.uoc.gr/(accessed September 2006).
27. Health Council of the Netherlands (2001) Dietary Reference Intakes: Energy, Proteins, Fats, and Digestible Carbohydrates. Report 19. The Hague: Health Council of the Netherlands.
28. Martin A (2001) Apports nutritionnels conseillés pour la population française, 3rd ed. Paris: Lavoisier.
29. National Health and Medical Research Council (2005) Nutrient Reference Values for Australia and New Zealand Including Recommended Dietary Intakes. Canberra: Australian Government, Department of Health and Ageing, NHMRC, Ministry of Health; available at http://www. nhmrc.gov.au/publications/synopses/ n35syn.htm
30. World Health Organization (2003) Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Series no. 916. Geneva: WHO; available at http://www.who.int/nut/documents/trs- 916.pdf
31. UK Scientific Advisory Committee on Nutrition (2004) Advice on fish consumption: benefits & risks. http://www.sacn.gov.uk/reports/(accessed September 2006).
32. Cunnane S, Drevon CA, Harris B, Sinclair A& Spector A (2004) Recommendations for intake of polyunsaturated fatty acids in healthy adults. International Society for Study of Fatty Acids and Lipids (ISSFAL) Subcommittee. http://www.issfal.org.uk/pufa%20intakes.htm (accessed September 2004).
33. American Dietetic Association (2007) Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 107, 1599-1611.
34. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M et al. (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82-96.
35. Simopoulos AP, Leaf A & Salem N Jr (1999) Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 43, 127-130. (Pubitemid 29373691)
36. Simopoulos AP (1989) Summary of the NATO advanced research workshop on dietary omega 3 and omega 6 fatty acids: biological effects and nutritional essentiality. J Nutr 119, 521-528.
37. British Nutrition Foundation (1992) Unsaturated Fatty Acids. Nutritional and Physiological Significance. The Report of the British Nutrition Foundation's Task Force. London: British Nutrition Foundation.
38. Van de Werf F, Ardissino D, Betriu A et al. (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 24, 28-66.
39. Health Canada (2005) Canadian Nutrient File. Health Canada. http://www.hc-sc.gc.ca/fn-an/nutrition/fiche-nutridata/index-e.html (accessed October 2006).
40. Mozaffarian D & Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885-1899.
41. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y & Tsugane S (2006) Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese. The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113, 195-202.
42. Innis SM & Elias SL (2003) Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women. Am J Clin Nutr 77, 473-478.
43. Denomme J, Stark KD & Holub BJ (2005) Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J Nutr 135, 206-211.
44. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR & Chance GW (1980) Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4, 121-129. (Pubitemid 10064580)
45. Martinez M (1992) Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120, s129-s138.
46. Harris WS & Von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212-220.
47. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB & Borkon AM (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients. Correlation with erythrocytes and response to supplementation. Circulation 110, 1645-1649.
48. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ & Eisenberg DM (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135, 262-268.
49. American Statistical Association (2004) What is a survey? ASA Series [F Scheuren, editor]. http://www.whatisasurvey. info/(accessed November 2006).
50. Johnson TP, Holbrook AL, Ik Cho Y & Bossarte RM (2006) Nonresponse error in injury-risk surveys. Am J Prev Med 31, 427-436.
51. Keeter S, Miller C, Kohut A, Groves RM & Presser S (2000) Consequences of reducing nonresponse in a national telephone survey. Public Opin Q 64, 125-148.
52. Curtin R, Presser S & Singer E (2000) The effects of response rate changes on the index of consumer sentiment. Public Opin Q 64, 413-428.
53. Hox JP & De Leeuw ED (1994) A comparison of nonresponse in mail, telephone, and face-to-face surveys: applying multilevel modeling to meta-analysis. Qual Quant 28, 329-344.
54. Burdge G (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7, 137-144.
55. Cantwell MM (2000) Assessment of individual fatty acid intake. Proc Nutr Soc 59, 187-191.
56. Blanchet C, Lucas M, Julien P, Morin R, Gingras S & Dewailly E (2005) Fatty acid composition of wild and farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Lipids 40, 529-531.
57. Schmier JK, Rachman NJ & Halpern MT (2006) The costeffectiveness of omega-3 supplements for prevention of secondary coronary events. Manag Care 15, 43-50.
58. Lamotte M, Annemans L, Kawalec P & Zoellner Y (2006) A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics 24, 783-795.